BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 230 filers reported holding BEAM THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.22 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,746,920 | -25.8% | 72,637 | -1.4% | 0.00% | 0.0% |
| Q2 2023 | $2,353,145 | +5.0% | 73,697 | +0.7% | 0.00% | 0.0% |
| Q1 2023 | $2,240,527 | -22.9% | 73,172 | -1.6% | 0.00% | -40.0% |
| Q4 2022 | $2,907,789 | -16.9% | 74,349 | +1.2% | 0.01% | -16.7% |
| Q3 2022 | $3,500,000 | +22.8% | 73,468 | -0.2% | 0.01% | +20.0% |
| Q2 2022 | $2,850,000 | -2.6% | 73,633 | +44.2% | 0.01% | +25.0% |
| Q1 2022 | $2,926,000 | -34.4% | 51,068 | -8.7% | 0.00% | -20.0% |
| Q4 2021 | $4,459,000 | -2.5% | 55,949 | +6.5% | 0.01% | -16.7% |
| Q3 2021 | $4,572,000 | -45.1% | 52,546 | -18.8% | 0.01% | -40.0% |
| Q2 2021 | $8,334,000 | +73.0% | 64,751 | +7.6% | 0.01% | +66.7% |
| Q1 2021 | $4,816,000 | -2.3% | 60,165 | -0.3% | 0.01% | -14.3% |
| Q4 2020 | $4,927,000 | +274.1% | 60,347 | +12.8% | 0.01% | +250.0% |
| Q3 2020 | $1,317,000 | +151.8% | 53,480 | +186.5% | 0.00% | +100.0% |
| Q2 2020 | $523,000 | +55.7% | 18,669 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $336,000 | – | 18,669 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 2,362,635 | $205,573,000 | 24.93% |
| HSG Holding Ltd | 796,089 | $69,268,000 | 6.22% |
| DC Investments Management, LLC | 21,010 | $1,828,000 | 3.41% |
| Redmile Group, LLC | 1,975,006 | $171,845,000 | 3.00% |
| Casdin Capital, LLC | 818,820 | $71,246,000 | 1.77% |
| Evolutionary Tree Capital Management, LLC | 44,390 | $3,862,000 | 1.71% |
| HHLR ADVISORS, LTD. | 1,448,161 | $126,004,000 | 1.65% |
| Nan Fung Group Holdings Ltd | 54,903 | $4,777,000 | 1.53% |
| ARK Investment Management | 6,841,722 | $595,298,000 | 1.43% |
| BRANDYWINE MANAGERS, LLC | 12,900 | $1,122,000 | 1.17% |